Acadia Pharmaceuticals Inc.
The Executive Director, Rare Disease Marketing will lead the U.S. launch of a new therapy for a rare neurodevelopmental disorder and shape the rare disease franchise strategy. This role involves developing and executing innovative U.S. HCP marketing strategies, collaborating cross-functionally to build brand positioning, disease awareness, and core messaging.